Xin Gao
Shanghai Zhongshan Hospital · Third Affiliated Hospital, Sun Yat-Sen University · Fudan University
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Xin Gao as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 06:38 UTC. Open this list on ClinicalTrials.gov
- N/ANCT04283942 · Effect of Intermittent Calorie Restriction on MASLD Patients With Abnormal Glucose MetabolismShanghai Zhongshan Hospital · completed · Fatty Liver Disease, Type 2 Diabetes, Impaired Glucose Regulation · study director
- Ph4NCT03971110 · A Study of Neoadjuvant Hormone Therapy in Patient With Advanced Prostate Cancer Undergoing Radical Prostatectomy.AstraZeneca · terminated · Advanced Prostate Cancer · principal investigator
- Ph2NCT03198572 · Efficacy and Safety of Berberine in Non-alcoholic SteatohepatitisFudan University · terminated · Non-alcoholic Steatohepatitis · principal investigator
- Ph4NCT02303730 · Exenatide Compared With Insulin Glargine to Change Liver Fat Content in Type 2 DiabetesFudan University · completed · Diabetes Mellitus, Type 2, Non-alcoholic Fatty Liver Disease · principal investigator
- Ph4NCT01720719 · Atorvastatin Versus Vitamin E in Treatment of Non-alcoholic Fatty Liver DiseaseXin Gao · unknown · Fatty Liver, Dyslipidemias, Diabetes Mellitus · principal investigator
- N/ANCT01110161 · Technical Validation of Lunar iDXA Visceral Fat ToolGE Healthcare · completed · Obesity · principal investigator
- Ph2NCT00633282 · Role of Pioglitazone and Berberine in Treatment of Non-Alcoholic Fatty Liver DiseaseXin Gao · completed · Nonalcoholic Fatty Liver Disease · principal investigator
- Ph3NCT00461617 · Double-Blind Comparison Between Mitiglinide and Nateglinide in Type 2 Diabetic PatientsKissei Pharmaceutical Co., Ltd. · completed · Diabetes · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 06:38 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 06:38 UTC. The ranking covers the 200 most relevant of 740 PubMed records, and a shared surname and initials can bring in a namesake. All 740 on PubMed
- Patients with Cancer Appear More Vulnerable to SARS-CoV-2: A Multicenter Study during the COVID-19 Outbreak.Cancer Discov · 20201,183 citationsRCR 55.1
- 649 citationsRCR 43.3
- Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation: The ULTIMATE Trial.J Am Coll Cardiol · 2018555 citationsRCR 24.3
- 3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation.JACC Cardiovasc Interv · 2021274 citationsRCR 17.5
- A practical VEP-based brain-computer interface.IEEE Trans Neural Syst Rehabil Eng · 2006245 citationsRCR 7.9
- FDA Approval Summary: (Daunorubicin and Cytarabine) Liposome for Injection for the Treatment of Adults with High-Risk Acute Myeloid Leukemia.Clin Cancer Res · 2019245 citationsRCR 10.2
- 185 citationsRCR 7.3
- 155 citationsRCR 20.8
- 107 citationsRCR 19.0
- Efficacy of exenatide and insulin glargine on nonalcoholic fatty liver disease in patients with type 2 diabetes.Diabetes Metab Res Rev · 2020104 citationsRCR 5.3